|
 |
CamptosarThis page contains recent news articles, when available, and an overview of Camptosar but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Camptosar (when available) Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. Irinotecan is a derivative of camptothecin. Camptothecins interact specifically with the enzyme topoisomerase I which relieves torsional strain in DNA by inducing reversible single-strand breaks. Irinotecan and its active metabolite SN-38 bind to the topoisomerase I-DNA complex and prevent religation of these single-strand breaks. Current research suggests that the cytotoxicity of Irinotecan is due to double-strand DNA damage produced during DNA synthesis when replication enzymes interact with the ternary complex formed by topoisomerase I, DNA, and either Irinotecan or SN-38. Mammalian cells cannot efficiently repair these double-strand breaks. The precise contribution of SN-38 to the activity of Irinotecan in humans is not known. Irinotecan is cell cycle phase-specific (S-phase). For the treatment of metastatic colorectal cancer (first-line therapy when administered with 5-fluorouracil and leucovorin) Mechanism Of Action: Irinotecan inhibits the action of topoisomerase I. Irinotecan prevents religation of the DNA strand by binding to topoisomerase I-DNA complex, and causes double-strand DNA breakage and cell death. News Articles on Irinotecan Camptosar US Market Revenue, 2002-2005 ----Aarkstore Enterprise - 05 Jan 2010 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to ... PRMinds (press release) Pfizer da apoyo integral a pacientes con cáncer - Jan 3, 2010 ...ventas a nivel mundial del orden de 846 millones de dólares con el medicamento Sutent, de 465 millones con Aromasin y de 563 millones con Camptosar. Rotativo de Querétaro Pfizer (PFE) Earns OK - Oct 20, 2009 ...loss of exclusivity of Camptosar in Europe Pfizer upped revenue guidance for the year to $49 to $50 billion from a previous range of $45 to $46 billion. 24/7 Wall St. (blog) Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and ... - Nov 5, 2009 Phase 1b Clinical Trial of IMO-2055 in Combination with Erbitux® and Camptosar® in Colorectal Cancer Patient recruitment is ongoing with three escalating ... Reuters Surging Interest Drives Third Year Announcement of Probiotic Research Grants - Oct 29, 2009 Yakult is also accredited in the pharmaceutical field for its development of Campto Injection (Camptosar), the first-line drug for colorectal cancer in ... Reuters Pfizer Reports Third-Quarter 2009 Results - Oct 20, 2009 ...due to the strong performance of Sutent, was partially offset by the unfavorable impact of the loss of exclusivity of Camptosar in Europe in July 2009. ... Reuters Avastin® eficaz contra glioblastoma recorrente - Oct 21, 2009 O tratamento com o fármaco Avastin® (bevacizumab), isolado ou em combinação com a quimioterapia Camptosar® (irinotecano), melhorou os resultados de doentes ... POP - Portal de Oncologia Portugês … , Hospira receive FDA approval to launch generic version of Camptosa... - Feb 27, 2008 Earlier Wednesday, Hospira (nyse: HSP - news - people ) Inc. also said it received FDA approval to launch its generic version of Camptosar. ... Forbes … Pharma wins approval to market generic Camptosar in Italy, Denmark - Mar 11, 2008 MUMBAI (Thomson Financial) - Dabur Pharma Ltd said it secured regulatory approval to market its generic version of Pfizer's chemotherapy drug, Camptosar, ... Forbes … cleared to market generic version of Pfizer's Camptosar by US FDA - Oct 30, 2007 ...tentative approval to its abbreviated new drug application, to market a generic version of Pfizer's Camptosar (Irinotecan Hydrochloride) injection. ... Forbes Pfizer profit doubles, but anti-smoking drug lags - Jul 23, 2008 ...which Pfizer no longer sells, and generic competition for cancer drug Camptosar, whose global sales fell 43 percent to $137 million. ... Reuters … Launches Colorectal Cancer Test To Determine Appropriate Camptosar... - Dec 6, 2005 The UGT1A1 Molecular Assay identifies patients who may be at increased risk for severe adverse reactions to Camptosar by detecting variations in the UGT1A1 ... webwire.com Abraxis generic cancer drug gets tentative FDA nod - Oct 5, 2007 N) cancer drug, Camptosar Injection. The biopharmaceutical company said it expects ... According to IMS data, sales of Camptosar Injection were about $527 ... Reuters New Data At ASCO Show CAMPTOSAR Is Key To Treating 1st Line … - Jun 6, 2006 Data presented today at the annual meeting of the American Society of Clinical Oncology (ASCO) demonstrated that CAMPTOSAR® (irinotecan HCL injection), ... Medical News Today - Medical News Today (press release) Medicare overpaid on drugs with new generics, report says - Aug 28, 2008 Payments for cancer drug irinotecan, sold by Pfizer Inc. as Camptosar, remained at more than double the average manufacturer's sales price after the generic ... Los Angeles Times Dabur Pharma may sell Irinotecan in US - Nov 1, 2007 ...in cancer treatment drugs, has received tentative approval to market the generic version of Pfizer's Camptosar (Irinotecan Hydrochloride) injection. ... Hindu Business Line Pfizer's Okay For Now But Pressures Loom - Oct 21, 2008 The loss of sales from Norvasc and Camptosar also hurt the company's earnings. Pfizer's blockbuster Lipitor had a sales decline of 13.0%, to $1.6 billion, ... Forbes Enzon's PEG-SN38 Shows Anti-Tumor Activity in Resistant Preclinical … - Jan 7, 2005 Data from this study showed that PEG-SN38 administered to Camptosar-resistant mice (those that did not respond to Camptosar treatment) resulted in a 25 ... businesswire.com Colon drug screen not necessary for all - Aug 31, 2007 Irinotecan, also known by its brand name Camptosar, is used as a second-line treatment for colorectal cancer and the US Food and Drug Administration ... United Press International New data at ASCO show CAMPTOSAR is key to treating 1st line … - Jun 5, 2006 ATLANTA, June 5 – Data presented today at the annual meeting of the American Society of Clinical Oncology (ASCO) demonstrated that CAMPTOSAR® (irinotecan ... eurekalert.org Neopharm's colon-cancer drug falls short - Mar 30, 2007 ...said its next steps could include more data analyses and possibly additional studies. LE-SN38 is the active metabolite of Pfizer's cancer drug Camptosar. United Press International FDA Approves Gene Test to Help in Dosing of Colorectal Cancer Drug - Aug 24, 2005 24-The FDA has approved a genetic test that will allow clinicians to maximize efficacy and safety of Camptosar (irinotecan), a drug used to treat colorectal ... MedPage Today In Brief / PHARMACEUTICALS; Watson to market cancer drug - Feb 22, 2008 Watson Pharmaceuticals Inc. won clearance to sell the first generic version of Pfizer Inc.'s cancer drug Camptosar. The Food and Drug Administration ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Phase II Clinical Trial of NeoPharm's LE-SN38 Initiated By NCI CALGB... - May 30, 2006 However, Camptosar(R) is converted into SN-38 in colorectal cancer cells at different rates in different patients, and this variability in conversion rates ... RedOrbit … GI: Small Benefit Seen for Erbitux Plus Camptosar in Refractory... - Jan 23, 2007 By Ed Susman, Contributing Writer, MedPage Today. ORLANDO, Jan. 23 -- Treatment-refractory advanced gastric cancers may respond to combination therapy with ... MedPage Today … Cancer Test to Determine Appropriate Camptosar(R) Dosage. - PR … - Dec 6, 2005 Genzyme Launches Colorectal Cancer Test to Determine Appropriate Camptosar(R) Dosage. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Stage IV Esophageal Cancer - Apr 16, 2006 Other agents that have been or are being evaluated include Camptosar® and Gemzar®. ... Camptosar® is another new chemotherapy drug with activity against ... Cancer Consultants FDA Safety Labeling Changes: Camptosar, Keppra, Prempro/Premphase - Sep 21, 2005 Sept. 21, 2005 — The US Food and Drug Administration (FDA) approved safety labeling revisions in June to advise that reduced dosing of irinotecan HCl is ... Medscape Camptosar - Irinotecan hydrochloride - Medical Drug - Sep 2, 2007 Camptosar is used as a component of first-line therapy in the treatment of metastatic cancer of the colon or rectum. It can also be used in such patients ... Virtual Medical Centre - The Virtual Medical Centre Cancer Therapy; New data show Camptosar is key to treating first line... - Jun 27, 2006 2006 JUN 27 - (NewsRx.com) -- Data presented at the annual meeting of the American Society of Clinical Oncology (ASCO) demonstrated that CAMPTOSAR ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Camptosar label should include genotype data, FDA panel says.(Clinical... - Feb 15, 2005 ROCKVILLE, MD. -- Increasingly, studies have shown that people with a particular genetic marker seem to be at increased risk for severe neutropenia when ... Free with registration - Family Practice News - AccessMyLibrary.com Pfizer's Camptosar Faces Generic Competition - Mar 10, 2008 Pfizer will see its $556 million Camptosar franchise eroded with the recent FDA approval of multiple generic versions of the chemotherapy agent. ... FDA news - FDA news (subscription) Next gen cancer prodrug to challenge Pfizer's Camptosar - Oct 18, 2007 By Anna Lewcock, 18-Oct-2007. French firm Diatos has created a second generation irinotecan cancer therapy using its patented peptide-based drug delivery ... In-PharmaTechnologist.com Aceon, Invader UGT1A1 Molecular Assay.(coronary artery disease … - Oct 1, 2005 Recommended Usage: to help oncologists individualize dosing of Camptosar. ... The Camptosar label has been updated to include the recommendation that a ... Free with registration - Skin & Allergy News - AccessMyLibrary.com … and Markets: Cytotoxic Therapies, Camptosar, Eloxatin and Xeloda... - Dec 1, 2006 DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets. com/reports/c46294) has announced the addition of Colorectal Cancer (CRC) ... $4.95 - Business Wire - ECNext Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL - Nov 3, 2008 MONTVALE, NJ, Nov. 3 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, PLIVA - Lachema as, has received ... International Business Times Establishing First-line Therapy Use is the Biggest Challenge Facing … - May 25, 2005 The cytotoxic therapy drug Camptosar, illustrates the significance of ... The fourth quarter of 2004 and first quarter of 2005 showed Camptosar is gaining ... $4.95 - Business Wire - ECNext Teva Announces Approval Of Generic Camptosar(R) - Mar 3, 2008 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the US Food and Drug Administration has granted final approval for the Company's ... Medical News Today - Medical News Today (press release) FDA gives greenlight for new treatment of head and neck cancer - Mar 5, 2006 Erbitux was previously approved by the FDA to be used in combination with Camptosar (irinotecan) for the treatment of colorectal cancer that no longer ... News-Medical.net MyFox Lubbock | Camptosar - Uses, Side Effects, Interactions,... - Mar 9, 2007 By Pharmacia and Upjohn. Irinotecan belongs to the group of cancer-fighting medications known as antineoplastics. It kills cancer cells by interfering with ... myFOXlubbock.com … : North American Trial Fails to Confirm Benefit for Irinotecan... - Jun 5, 2008 CHICAGO, June 5 -- Irinotecan (Camptosar) plus cisplatin (Platinol) failed to demonstrate a survival benefit in a large North American trial of patients ... MedPage Today FDA Warns About Hypomagnesemia Due to Erbitux® - Sep 13, 2005 ...fatigue and symptomatic hypocalcemia, and hypomagnesemia in a 34-year-old patient receiving Erbitux and Camptosar® (irinotecan) for colorectal cancer. ... Cancer Consultants POSITIVE FINAL DATA FROM HYCAMP TRIAL IN METASTATIC … - May 29, 2007 The improved tumour control rates (76 per cent in the HyCAMP arm versus 46 per cent in the Camptosar arm) are very consistent with the differences in the ... Free with registration - AsiaPulse News - AccessMyLibrary.com APP Pharmaceuticals Receives Final Approval For Irinotecan … - Mar 3, 2008 According to IMS data, sales of Camptosar® in the United States were approximately ... Pfizer's Camptosar® Injection is a chemotherapy drug used to treat ... Medical News Today - Medical News Today (press release) Merck KGaA: Erbitux seeks EMEA approval for line-extension - Sep 4, 2007 In February 2004, Erbitux was approved in the US and in June 2004 in the EU, for use in combination with Camptosar in advanced disease and as a monotherapy ... Pharmaceutical Business Review Biotech firm Third Wave continues business transition. - Jul 28, 2005 ...approval of its test to screen for adverse reactions to Camptosar, a chemotherapy drug by Pfizer that's commonly used by colon cancer patients. ... Free with registration - WI State Journal - AccessMyLibrary.com Diagnostics; UGT1A1 gene variants test for dosing colorectal cancer … - Mar 14, 2006 UGT1A1 gene associated with excessive toxicity in individuals treated with the late-stage colorectal cancer drug irinotecan hydrochloride (Camptosar). ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Generic Camptosar.(RX: RETAIL PHARMACY: Generic Drugs)(Sandoz … - Mar 17, 2008 Generic Camptosar.(RX: RETAIL PHARMACY: Generic Drugs)(Sandoz has introduced irinotecan hydrochloride, a generic equivalent of Camptosar)(Brief article) ... Pay-Per-View - Chain Drug Review - HighBeam Research Pro-Pharmaceuticals seeks quick FDA approval - Jun 11, 2007 Irinotecan is marketed by Pfizer Inc. in the US as Camptosar. "Our goal is to get our lead compound, Davanat, to market with multiple chemotherapy drugs," ... Triangle Business Journal Irinotecan May Improve 5-Fluorouracil/Leucovorin Combination in Stage... - May 18, 2005 May 18, 2005 (Orlando) — Adding irinotecan (Camptosar) to the standard chemotherapy combination of 5-fluorouracil and leucovorin may increase disease-free ... Medscape … Release: Barr Announces Approval of Generic Camptosar(R) Injection,... - Nov 3, 2008 Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research The Colorectal Drug Pipeline Update 2007 Lists All Drugs and Gives... - Aug 27, 2007 Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as ... Free with registration - Business Wire - AccessMyLibrary.com FDA approves Invader UGT1A1 assay. - Aug 29, 2005 Camptosar, used in the treatment of colorectal cancer, was recently re-labelled to include dosage instructions related to the patients genetic profile. ... $4.95 - Pharma Marketletter - ECNext Generic Camptosar. - Mar 17, 2008 Generic Camptosar. Sandoz has introduced irinotecan hydrochloride, a generic equivalent of Camptosar. The injectable oncological product is typically used ... $9.94 - Chain Drug Review - Alacra Store Pfizer's Growing Strength in Oncology - May 29, 2007 In 2006, Pfizer's currently marketed products -- including Camptosar, Aromasin, Sutent -- accounted for approximately $1.9 billion in revenues, ... Genetic Engineering News - Genetic Engineering News (press release) Cost Cuts and Weak Dollar Lift Pfizer - Jan 23, 2008 ...might not be comparable to the first quarter of 2007 because of the loss of US exclusivity of key drugs, such as Norvasc, Camptosar, and Zyrtec. ... Portfolio.com Newer Chemo Regimens Prolong Survival in Advanced Colorectal … - Sep 24, 2007 ...the estimated absolute survival benefit of additional treatment with irinotecan (Camptosar) plus bevacizumab (Avastin) was an added eight months, ... MedPage Today ALSO NOTED: Barr gets FDA's blessing for generic Taxol; Biovail... - Mar 13, 2008 In February the FDA approved nine first-time generic meds, including versions of the osteoporosis med Fosamax, the cancer drug Camptosar, and the heartburn ... FiercePharma Dabur Pharma unveils irinotecan hydrochloride injection in US - Feb 29, 2008 Irinotecan Injection is the generic version of Camptosar, which had sales of over USD 556 million in the US (IMS - MAT 03/07). Irinotecan is indicated as a ... Myiris.com Dabur Pharma net drops 7.51% in Dec`07 qtr - Feb 1, 2008 ...abbreviated new drug application (ANDA) to market it`s generic version of Pfizer`s Camptosar (Irinotecan Hydrochloride) injection 40mg and 100mg. ... Myiris.com How to take Sorafenib from Consumer Reports Health. - Jan 8, 2007 ...ifosfamide, irinotecan (Camptosar), methadone (Dolophine, Methadose), phenobarbital, phenytoin (Dilantin, Phenytek), or rifampin (Rifadin, Rimactane). ... consumerreports.org Unmasking a "cure".(www.cancercure.org)(Website overview) | Article … - Apr 1, 2006 But Camptosar is not dramatically effective in treating advanced disease. ... So the thought of Camptosar being sold as an over-the-counter pill via the ... Pay-Per-View - Townsend Letter: The Examiner of... - HighBeam Research Enzon's PEG-SN38 Shows Anti-Tumor Activity in Resistant Preclinical … - Apr 17, 2007 Data from this study showed that PEG-SN38 administered to Camptosar-resistant mice (those that did not respond to Camptosar treatment) resulted in a 25 ... Free with registration - Business Wire - AccessMyLibrary.com Cetuximab (Erbitux®) Safely Added to FOLFIRI as First-Line Treatment... - Jun 2, 2006 It is also approved for treatment with Camptosar in patients with ... The addition of cetuximab to Camptosar-based therapies has demonstrated a significant ... Cancer Consultants Press Release: /SECOND AND FINAL ADD -- NYTU041B -- Pfizer Inc … - Apr 19, 2005 A30) Sales of Campto/Camptosar totaled $212 million in the first quarter of ... The worldwide presence of Campto/Camptosar has driven the growth of this ... Pay-Per-View - PR Newswire - HighBeam Research United States: FDA Confirms Its View On Generic Drug Label Carve-Outs - Feb 9, 2008 The Camptosar ® decision clarifies questions surrounding whether and to what extent a ... FDA's recent Camptosar ® decision has apparently resolved—perhaps ... Mondaq News Alerts - Mondaq News Alerts (Registration) LabCorp Launches UGT1A1 Dx Licensed from Mayo Medical Labs - Feb 15, 2006 Sales of Camptosar, whose generic name is irinotecan, may prove to be a useful ... According to unaudited financial reports from Pfizer, Camptosar generated ... genomeweb.com Erbitux has modest benefit as first-line colorectal cancer drug - Jun 4, 2007 Erbitux already is approved to treat people with advanced colorectal cancer, in combination with Pfizer Inc.'s Camptosar after Camptosar has failed to halt ... MarketWatch Lucro da Pfizer cresce 19% no 1º semestre do ano - Jul 23, 2008 ...no paÃs, do medicamento para parar de fumar Chantix ea perda da proteção da patente do remédio contra a alergia Zyrtec e contra o câncer Camptosar. ... G1.com.br Lucro da Pfizer quase triplica em relação a 3º trimestre de 2007 - Oct 21, 2008 ...monopólio e da patente nos Estados Unidos do anti-histamÃnico Zyrtec, assim como dos remédios Camptosar, contra o câncer, e Norvasc, para a hipertensão. ... G1.com.br יו×? ×?': הבורסה × × ×¢×œ×” בירידות חדות: המעו"×£ ×¦× ×— ב-3.2% - Mar 2, 2008 ...ביו×? חמישי קיבלה החברה ×?ישור FDA לשיווק גרסה ×’× ×¨×™×ª לתרופת ×”-Camptosar של פייזר לטיפול בחולי ... ynet ידיעות ×?×—×¨×•× ×•×ª - ynet ידיעות ×?×—×¨×•× ×•×ª Enzon Commences Enrollment of Two Phase 1 Studies of PEG-SN38 for … - Aug 1, 2007 The data showed that treatment with the PEGylated SN38 resulted in significant tumor growth inhibition in mice resistant to Camptosar and outperformed ... Free with registration - Business Wire - AccessMyLibrary.com Update on Advanced Colon Cancer—ASCO 2005 - May 13, 2005 This was a 3-arm phase III study of 822 patients with progressive metastatic colorectal cancer after 5-FU and Camptosar® (irinotecan) who had not received ... Cancer Consultants ASCO 2006: Update on the Management of Colorectal Cancer - Jun 2, 2006 The conclusion of this trial, which supports much previous data, is that the infusional 5FU regimen is superior to bolus 5FU when combined with Camptosar. ... Cancer Consultants Colon Cancer; Establishing first-line therapy use challenge for US … - Jun 20, 2005 The cytotoxic therapy drug Camptosar illustrates the significance of first-line ... The fourth quarter of 2004 and first quarter of 2005 showed Camptosar is ... Pay-Per-View - Gastroenterology Week - Factiva, from Dow Jones Farmacéutica Pfizer gana un 45% más en los nueve primeros meses del … - Oct 21, 2008 ...y de la patente en Estados Unidos del antihistamÃnico Zyrtec, asà como de los fármacos Camptosar, contra el cáncer, y Norvasc, para la hipertensión. ... ADN.es Primul citostatic fabricat în România, comercializat în SUA - Mar 3, 2008 Clorhidratul de Irinotecan sub formă injectabilă este echivalentul generic al produsului Pfizer Camptosar ÅŸi va fi disponibil sub formă de fiole ... Evenimentul Zilei Colon Cancer; Establishing first-line therapy use challenge for US … - Jun 21, 2005 The cytotoxic therapy drug Camptosar illustrates the significance of first-line ... The fourth quarter of 2004 and first quarter of 2005 showed Camptosar is ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Enzon Provides New Data on Customized Linker Technology. - Oct 30, 2007 The study also demonstrated that treatment with PEG-SN38 resulted in remarkable tumor growth inhibition in animals with tumors resistant to Camptosar. ... Free with registration - Business Wire - AccessMyLibrary.com Neopharm faces uncertain future after 'lacklustre' trial results - Apr 4, 2007 SN38 is the active metabolite of Camptosar - it is formed when Pfizer's approved cancer drug, Camptosar (irinotecan) is broken down in the body. ... DrugResearcher.com КомпаниÑ? APP получила предварительное разрешение FDA на … - Oct 11, 2007 который Ñ?влÑ?етÑ?Ñ? дженериковым аналогом инъекционного препарата Camptosar(R) американÑ?кой компании Pfizer Inc. Препарат будет выпуÑ?катьÑ?Ñ? в ампулах ... ФармацевтичеÑ?кий веÑ?тник КомпаниÑ? Pfizer International обнародовала финанÑ?овые результаты … - Jul 25, 2008 Ðти факторы более чем компенÑ?ируют Ñ?нижение доходов, вызванное утратой Ñ?кÑ?клюзивноÑ?ти препаратов Zyrtec (втораÑ? половина Ñ?нварÑ? 2008 года) и Camptosar (в ... МедÐ?овоÑ?ти Press Release: /SECOND AND FINAL ADD -- NYW043A -- Pfizer Inc … - Jan 19, 2005 Q32) How is Campto/Camptosar performing? A32) Worldwide sales of Campto/Camptosar totaled $189 million in the fourth quarter of 2004, reflecting growth of ... Pay-Per-View - PR Newswire - HighBeam Research PFIZER INC : Le bénéfice net trimestriel grimpe à 2,3 Mds$ - Oct 21, 2008 Nos ventes sont pratiquement stables sur un an malgré la perte de l'exclusivité du Zyrtec ainsi que du Camptosar ' indique le groupe, en précisant que les ... La Vie Financière Far From Benign - Dec 22, 2005 Prescription-only Camptosar has potentially fatal side effects — "it would knock people's socks ... Camptosar is injected and can't be made into pill form. ... Broward New Times FDA to Consider Relabeling Tamoxifen for 2D6 Response in Fall Meeting... - Jun 14, 2006 The agency relabeled Pfizer's Camptosar in June last year, and it decided ... With Camptosar, the first relabeling instance, the agency included information ... genomeweb.com Phase II Clinical Trial of NeoPharm's LE-SN38 Initiated by NCI CALGB... - Apr 23, 2006 However, Camptosar(R) is converted into SN-38 in colorectal cancer cells at different rates in different patients, and this variability in conversion rates ... businesswire.com … suggests that not everyone needs a genetic test prior to taking... - Sep 13, 2007 Irinotecan, also known as Camptosar, is used as a second-line treatment for colorectal cancer. The FDA recommends screening for a gene that could make ... TopCancerNews.com Mobile - News, Events, Restaurants, Music from Broward/Palm Beach - … - Oct 22, 2006 Prescription-only Camptosar has potentially fatal side effects — "it would knock people's socks ... Camptosar is injected and can't be made into pill form. ... Broward New Times Third Wave and Genzyme Genetics Announce Preferred Marketing … - Oct 27, 2005 The Invader UGT1A1 Molecular Assay identifies patients who may be at increased risk for adverse reactions to Camptosar by detecting variations in the UGT1A1 ... Free with registration - PR Newswire - AccessMyLibrary.com Enzon Receives FDA Clearance of Its Recently Filed PEG-SN38 IND … - Apr 30, 2007 SN38 is the active metabolite of the widely used cancer drug irinotecan, marketed as Camptosar(R) in the US Although unmodified SN38 is significantly more ... Genetic Engineering News - Genetic Engineering News (press release) Enzon Starts Enrollment for Phase I Cancer Drug Trial - Aug 2, 2007 The studies of PEG-SN38, Enzon's pegylated form of SN38, the active metabolite of the cancer drug Camptosar, are designed to evaluate the safety, ... RedOrbit Studies Question Survival Benefit of Initial Aggressive Combination … - Jul 14, 2007 5-FU-Leucovorin with Camptosar or 5-FU-Leucovorin with Eloxatin. Response rates were higher in patients receiving initial combination chemotherapy. ... Cancer Consultants GENETIC SCREENING CAN MAKE CANCER DRUGS MORE … - Sep 13, 2005 McLeod's work helped identify a variation of a gene called UGT1A1, which is involved in the breakdown of Camptosar in the body. This variant increases the ... $2.95 - Belleville News-Democrat - NewsBank Press Release: Hospira Launches Generic Irinotecan Injection. - PR … - Feb 27, 2008 The medication is a generic version of Pfizer's Camptosar(R), which posted 2007 U.S. sales of ... Article: Study Reports Survival Benefits of CAMPTOSAR(r) . ... Pay-Per-View - PR Newswire - HighBeam Research Article: Invader UGT1A1 molecular assay.(genetic mutations ) -... - Sep 15, 2005 The Camptosar label has been ... individualizing drug therapy, FDA's approval of this assay provides ... Skin & Allergy News. Article: Aceon, Invader UGT1A1 ... Pay-Per-View - Internal Medicine News - HighBeam Research PFIZER INC - 1st Quarter Results. | Article from PR Newswire UK... - Apr 19, 2005 The strong performance of Camptosar during the first quarter, with revenue ... In the U.S., which represents approximately half of total Camptosar worldwide ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research EDITED BRIEF - Apr 17, 2008 Lost exclusivity of Camptosar in Feb. 2008, impact was less than other products. ... of Norvasc, Zyrtec, and Camptosar, for a total decrease of $937m. ... $54.00 - Thomson StreetEvents - Alacra Store Chemotherapy's Juggernaut - Jun 2, 2005 Genentech's Avastin was tested with Taxol in non-small-cell lung cancer (see "Genentech's Triumph"), and can be used with either Eloxatin or Camptosar, ... Forbes Q3 2005 ENZON PHARMACEUTICALS INC Earnings Conference Call - … - May 5, 2005 He has directed the development and commercialization of several successful brands including Camptosar at Pharmacia, INTRON A at Schering-Plough, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Enzon Presents New PEG-SN38 Preclinical Data at ASH. - Dec 10, 2007 SN38 is the active metabolite of the widely used cancer drug CPT-11, marketed as Camptosar[R] in the US Although unmodified SN38 is 1000 times more potent ... Free with registration - Business Wire - AccessMyLibrary.com ASCO GI: EGFR Antibody Therapy Demonstrates Efficacy in Colorectal … - Jan 25, 2007 ...with little to no rash response at the standard dosing (400 mg/m 2 followed by 250 mg/m 2 /week plus Camptosar (irinotecan) 180 mg/m 2 every two weeks). ... MedPage Today Genentech/Roche: Significant Potential for Avastin in Glioma - Feb 19, 2007 In addition, the combination of Avastin and Camptosar was capable of delaying tumor growth by at least six months in 38% of patients. ... RedOrbit Gentris to Enter IVD Market with Warfarin Dx As Shops Await FDA s … - May 10, 2006 The UGT1A1 test's market includes "any and all patients" prescribed Camptosar (or its generic version irinotecan), said Murphy. ... genomeweb.com A Menace to Big Pharma - Oct 8, 2007 Camptosar is a chemotherapy treatment for cancer and has a patent set to expire in February, at which time Abraxis hopes to cash in. ... fool.com Daily Cancer News - Nov 5, 2007 To explore the safety and efficacy of adding Avastin to chemotherapy with Paraplatin and Camptosar, researchers are conducting a Phase II clinical trial ... Cancer Consultants Pharmacogenetic cancer test receives FDA clearance - Aug 23, 2005 Camptosar is used to treat colorectal cancer and was relabelled recently to include dosing recommendations based on a patient's genetic profile. ... LabTechnologist.com Brand Names/Synonyms: Camptosar is also known by the following brand names and/or synonymsCP0; Camptosar; IRINOTECAN, CPT-11; Irinotecan; Irinotecan Hcl; Irinotecan Hydrochloride; Irinotecan Hydrochloride Trihydrate; Irinotecanum [Inn-Latin] Drug Category: Camptosar is categorized under the following by the FDA: Radiation-Sensitizing Agents; Prodrugs; Parasympathomimetics; Antineoplastic Agents; Enzyme Inhibitors; ATC:L01XX19 Dosage Forms: IV Solution Absorption: 100% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: irinotecan hydrochloride |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |